Scancell to work with Dutch firm on first product for Moditope cancer immuno-therapy platform Dutch group ISA Pharmaceutical will incorporate its Amplivant technology into Modi-1, the first cancer treatment candidate being developed on the platform [View article] Thursday 15 February 2018 20:00 Categories: Media Coverage Modi-1 Moditope Year - 2018 Previous Post << >> Next Post